Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Debt Ratio (2019 - 2025)

Tg Therapeutics (TGTX) has 7 years of Debt Ratio data on record, last reported at 0.23 in Q4 2025.

  • For Q4 2025, Debt Ratio fell 45.4% year-over-year to 0.23; the TTM value through Dec 2025 reached 0.23, down 45.4%, while the annual FY2025 figure was 0.23, 45.4% down from the prior year.
  • Debt Ratio reached 0.23 in Q4 2025 per TGTX's latest filing, down from 0.24 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.49 in Q1 2023 and bottomed at 0.04 in Q3 2021.
  • Average Debt Ratio over 5 years is 0.28, with a median of 0.29 recorded in 2023.
  • Peak YoY movement for Debt Ratio: plummeted 80.85% in 2021, then soared 735.99% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.18 in 2021, then soared by 105.88% to 0.37 in 2022, then decreased by 17.34% to 0.3 in 2023, then soared by 39.29% to 0.42 in 2024, then crashed by 45.4% to 0.23 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.23 in Q4 2025, 0.24 in Q3 2025, and 0.35 in Q2 2025.